Skip to main content

Pravastatin prevents the progression of accelerated coronary artery disease after heart transplantation in a rabbit model

  • Conference paper
Transplant International

Abstract

This study was designed to investigate the effects of pravastatin (Pr) on accelerated coronary arteriosclerosis in transplanted hearts. The rabbit hearts were transplanted to the recipients’ neck heterotopically, and received FK506. The rabbits in group 1 were fed a normal diet (ND), and cholesterol-rich diet (CD) in group 2 and 3. Pr (10 mg/kg) was given to group 3. They were sacrificed at 4 weeks and the severity of myocardial rejection and arteriosclerosis was assessed and scored histologically. The serum lipid levels were significantly elevated by a CD. However, addition of Pr had no effect on the levels of LDL and total cholesterol (TC). There was no significant difference in myocardial rejection in each group. Transplanted hearts in group 2 showed more severe arteriosclerotic lesions than those in group 1. Pr treatment in group 3 diminished the severity of coronary arteriosclerosis. Pr may prevent the accelerated coronary arteriosclerosis after heart transplantation without significant changes in TC and LDL.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Alonso DR, Starek PF, Minick CR (1977) Studies on pathogenesis of atheroarteriosclerosis induced in rabbit cardiac allografts by synergy of graft rejection and hypercholesterolemia. Am J Pathol 87: 415–422

    PubMed  CAS  Google Scholar 

  2. Billingham ME (1987) Cardiac transplant atherosclerosis. Transplant Proc 19: 19–25

    PubMed  CAS  Google Scholar 

  3. Billingham ME, Cary NRB, Hammond ME, Kemnitz J, Marboe C, McCallister HA, Snovar DC, Winters GL, Zerbe A (1990) A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: heart rejection study group. J Heart Transplant 9: 587–593

    PubMed  CAS  Google Scholar 

  4. Carrel A (1907) The surgery of blood vessels, etc. Bull Johns Hobkins Hosp 18: 18

    Google Scholar 

  5. Corsini A, Rainteri M, Soma MR, Gabbiani G, Paoletti R (1992) Simvastatin but not pravastatin has a direct inhibitory effect on rat and human myocyte proliferation. Clin Biochem 25: 399–400

    Article  PubMed  CAS  Google Scholar 

  6. Eich D, Thompson JA, Ko D, Hatillo A, 10. Lower R, Katz S, Katz M, Hess ML (1991) Hypercholesterolemia in long term survivors of heart transplantation. An early marker of accelerated coronary artery disease. J Heart Lung Transplant 10: 45–49

    CAS  Google Scholar 

  7. Gao SZ, Schroeder JS, Alderman EL, 11. Hunt SA, Silverman JF, Wiederhold V, Stinson EB (1987) Clinical laboratory correlates of accelerated coronary ar- 12. tery disease in the cardiac transplant patient. Circulation 76: 56–61

    Google Scholar 

  8. Grattan MT, Moreno-Cabral CE, Starnes VA, Oyer Pe, Stinson EB, Shumway NE (1989) Cytomegalovirus infection is 13. associated with cardiac allograft rejection and atherosclerosis. J Am Med Assoc 261: 3561–3566

    Article  CAS  Google Scholar 

  9. Hidaka Y, Eda T, Yonemoto M, Kamei T (1992) Inhibition of cultured vascular smooth muscle cell migration by sim- 14. vastatin (MK-733). Atherosclerosis 95: 87–94

    Article  PubMed  CAS  Google Scholar 

  10. Meiser BM, Wenke K, Thiery J, Wolf S, Devens Ch, Seidel D, Hammer C, Bellingham ME, Reichart B (1993) Simvastatin decreases accelerated graft vessel disease after heart transplantation in an animal model. Transplant Proc 25: 2077–2079

    PubMed  CAS  Google Scholar 

  11. Ross R (1993) The pathogenesis of atherosclerosis: a perspective for the 1990s. Science 362: 801–809

    CAS  Google Scholar 

  12. Sarris GE, Mitchell RS, Gillingham ME, Glasson JR, Cahill PD, Miller DC (1989) Inhibition of accelerated cardiac allograft arteriosclerosis by fish oil. J Thorac Cardiovasc Surg 97: 841–855

    PubMed  CAS  Google Scholar 

  13. Shibata T, Ogawa N, Koyama I, Kaneko N, Hokazono K, Omoto R (1993) FK506 accelerates the development of coronary artery disease in the transplanted heart as well as the native heart? Transplant Proc 25: 1145–1148

    PubMed  CAS  Google Scholar 

  14. Soma MR, Dometti E, Parolini C, Ferrari G, Fumagalli R, Paoletti R (1993) HMG COA reductase inhibitors — In vivo effects on carotid intimai thickening in normocholesterolemic rabbits. Arterioscler Thromb 13: 266–273

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1996 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Ogawa, N. et al. (1996). Pravastatin prevents the progression of accelerated coronary artery disease after heart transplantation in a rabbit model. In: MĂĽhlbacher, F., et al. Transplant International . Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-00818-8_58

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-00818-8_58

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-61024-3

  • Online ISBN: 978-3-662-00818-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics